• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6-羟基-L-尼古丁在代表性癌细胞系中的独特生物学效应

The Distinct Biological Effects of 6-Hydroxy-L-Nicotine in Representative Cancer Cell Lines.

作者信息

Postu Paula Alexandra, Boiangiu Razvan Stefan, Mihasan Marius, Stache Alexandru Bogdan, Tiron Adrian, Hritcu Lucian

机构信息

Center for Fundamental Research and Experimental Development in Translation Medicine-TRANSCEND, Regional Institute of Oncology, 700483 Iasi, Romania.

Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.

出版信息

Molecules. 2024 Nov 26;29(23):5593. doi: 10.3390/molecules29235593.

DOI:10.3390/molecules29235593
PMID:39683752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11643659/
Abstract

6-hydroxy-L-nicotine (6HLN) is a nicotine (NIC) derivative with proven therapeutic potential in neurodegenerative disorders. Here, the impact of 6HLN on cell growth, migratory behavior, and inflammatory status of three different cancer cell lines (A549, MCF7, and U87) and two normal cell lines (16HBE14o and MCF10A) was investigated. In silico analyses were conducted to evaluate the binding affinity of 6HLN to nicotinic receptors (nAChRs) containing α9 and α5 subunits. The obtained in silico data revealed that 6HLN might act on the cholinergic system. Interestingly, the in vitro data showed the compound has cancer-stimulatory effects in U87 glioblastoma cells and cancer-inhibitory effects in MCF7 breast cancer cells. In A549 lung cancer cells, no changes were detected upon 6HLN administration. More importantly, 6HLN appears not to be deleterious for normal cells, with the viability of 16HBE14o pulmonary cells and MCF10A mammary cells remaining unchanged.

摘要

6-羟基-L-尼古丁(6HLN)是一种尼古丁(NIC)衍生物,在神经退行性疾病中具有已被证实的治疗潜力。在此,研究了6HLN对三种不同癌细胞系(A549、MCF7和U87)以及两种正常细胞系(16HBE14o和MCF10A)的细胞生长、迁移行为和炎症状态的影响。进行了计算机模拟分析,以评估6HLN对含有α9和α5亚基的烟碱受体(nAChRs)的结合亲和力。获得的计算机模拟数据显示,6HLN可能作用于胆碱能系统。有趣的是,体外数据表明该化合物对U87胶质母细胞瘤细胞具有癌症刺激作用,对MCF7乳腺癌细胞具有癌症抑制作用。在A549肺癌细胞中,给予6HLN后未检测到变化。更重要的是,6HLN似乎对正常细胞无害,16HBE14o肺细胞和MCF10A乳腺细胞的活力保持不变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/9d0e198cee6a/molecules-29-05593-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/f8089d88489f/molecules-29-05593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/0eae0e62b15e/molecules-29-05593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/df168c6f1a34/molecules-29-05593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/a13c1abd82ca/molecules-29-05593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/4da8e89e76fc/molecules-29-05593-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/1fd5c4006a5f/molecules-29-05593-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/305b9a08d43d/molecules-29-05593-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/0ceac110bbcb/molecules-29-05593-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/9d0e198cee6a/molecules-29-05593-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/f8089d88489f/molecules-29-05593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/0eae0e62b15e/molecules-29-05593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/df168c6f1a34/molecules-29-05593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/a13c1abd82ca/molecules-29-05593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/4da8e89e76fc/molecules-29-05593-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/1fd5c4006a5f/molecules-29-05593-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/305b9a08d43d/molecules-29-05593-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/0ceac110bbcb/molecules-29-05593-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/471d/11643659/9d0e198cee6a/molecules-29-05593-g009.jpg

相似文献

1
The Distinct Biological Effects of 6-Hydroxy-L-Nicotine in Representative Cancer Cell Lines.6-羟基-L-尼古丁在代表性癌细胞系中的独特生物学效应
Molecules. 2024 Nov 26;29(23):5593. doi: 10.3390/molecules29235593.
2
α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.α9-和α7 型受体介导尼古丁在 A549 腺癌细胞系中的促增殖作用。
Br J Pharmacol. 2018 Jun;175(11):1957-1972. doi: 10.1111/bph.13954. Epub 2017 Sep 8.
3
Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.姜黄素通过下调烟碱型乙酰胆碱受体和细胞周期蛋白 D3 蛋白抑制尼古丁诱导的人乳腺癌细胞增殖。
Breast Cancer Res Treat. 2011 Jan;125(1):73-87. doi: 10.1007/s10549-010-0821-3. Epub 2010 Mar 13.
4
Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.胆碱和尼古丁通过结合并激活含有α7 和α9 的烟碱型乙酰胆碱受体促进神经胶质瘤细胞增殖。
Pharmacol Res. 2021 Jan;163:105336. doi: 10.1016/j.phrs.2020.105336. Epub 2020 Dec 1.
5
Cotinine and 6-Hydroxy-L-Nicotine Reverses Memory Deficits and Reduces Oxidative Stress in Aβ-Induced Rat Model of Alzheimer's Disease.可替宁和6-羟基-L-尼古丁可逆转β-淀粉样蛋白诱导的阿尔茨海默病大鼠模型中的记忆缺陷并减轻氧化应激。
Antioxidants (Basel). 2020 Aug 18;9(8):768. doi: 10.3390/antiox9080768.
6
Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.烟碱型乙酰胆碱受体的差异表达与人类乳腺癌相关,并介导αO-芋螺毒素 GeXIVA 的抗肿瘤活性。
Mar Drugs. 2020 Jan 17;18(1):61. doi: 10.3390/md18010061.
7
Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors.叶黄素和槲皮素联合治疗通过下调烟碱型乙酰胆碱受体增强尼古丁处理的 MDA-MB-231 细胞的抗增殖作用。
J Agric Food Chem. 2010 Jan 13;58(1):235-41. doi: 10.1021/jf9031684.
8
α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cells.α5-烟碱型乙酰胆碱受体调节尼古丁诱导的A549肺癌细胞迁移和侵袭。
Exp Toxicol Pathol. 2015 Sep;67(9):477-82. doi: 10.1016/j.etp.2015.07.001. Epub 2015 Jul 20.
9
αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.αO-芋螺毒素 GeXIVA 通过与α9 型烟碱型乙酰胆碱受体相互作用抑制乳腺癌细胞的生长。
Mar Drugs. 2020 Apr 7;18(4):195. doi: 10.3390/md18040195.
10
The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers.α9 烟碱型乙酰胆碱受体在三阴性乳腺癌中的血管生成作用。
Angiogenesis. 2024 Nov;27(4):827-843. doi: 10.1007/s10456-024-09944-6. Epub 2024 Aug 23.

本文引用的文献

1
The relationship between nonsteroidal anti-inflammatory drugs and cancer incidence: An umbrella review.非甾体抗炎药与癌症发病率之间的关系:一项汇总分析。
Heliyon. 2024 Jan 12;10(2):e23203. doi: 10.1016/j.heliyon.2023.e23203. eCollection 2024 Jan 30.
2
Targeting Alpha7 Nicotinic Acetylcholine Receptors in Lung Cancer: Insights, Challenges, and Therapeutic Strategies.肺癌中α7烟碱型乙酰胆碱受体的靶向作用:见解、挑战与治疗策略
ACS Pharmacol Transl Sci. 2023 Dec 21;7(1):28-41. doi: 10.1021/acsptsci.3c00138. eCollection 2024 Jan 12.
3
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
白细胞介素-6控制的、基于间充质干细胞的钠/碘同向转运体基因疗法可提高荷胶质母细胞瘤小鼠的存活率。
Mol Ther Oncolytics. 2023 Aug 15;30:238-253. doi: 10.1016/j.omto.2023.08.004. eCollection 2023 Sep 21.
4
Nicotinic acetylcholine receptors in cancer: Limitations and prospects.烟碱型乙酰胆碱受体在癌症中的作用:局限性与展望。
Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166875. doi: 10.1016/j.bbadis.2023.166875. Epub 2023 Sep 4.
5
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
6
α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling.α7 烟碱型乙酰胆碱受体与 G 蛋白在乳腺癌细胞增殖、迁移和钙信号转导中的相互作用。
PLoS One. 2023 Jul 25;18(7):e0289098. doi: 10.1371/journal.pone.0289098. eCollection 2023.
7
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications.神经递质系统在重大神经障碍发病机制中的作用:新的认识和治疗意义。
Ageing Res Rev. 2023 Aug;89:101994. doi: 10.1016/j.arr.2023.101994. Epub 2023 Jun 28.
8
Cancer neuroscience: State of the field, emerging directions.癌症神经科学:领域现状,新兴方向。
Cell. 2023 Apr 13;186(8):1689-1707. doi: 10.1016/j.cell.2023.02.002.
9
IL-6: The Link Between Inflammation, Immunity and Breast Cancer.白细胞介素-6:炎症、免疫与乳腺癌之间的联系
Front Oncol. 2022 Jul 18;12:903800. doi: 10.3389/fonc.2022.903800. eCollection 2022.
10
Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention.从历史角度看非甾体抗炎药及其在癌症治疗和预防药物再利用方面的现状。
J Cancer Res Clin Oncol. 2023 May;149(5):2095-2113. doi: 10.1007/s00432-022-04187-8. Epub 2022 Jul 25.